NAROPEINE Side Effects

6019463-3 | Monoplegia
on Dec 18, 2008 Female patient from FRANCE , 24 years of age, was diagnosed with nerve block, postoperative care, prophylaxis of nausea and vomiting and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: monoplegia. Naropeine dosage: . During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), SUFENTANIL (View Sufentanil Review and Sufentanil Label ), DROLEPTAN (View Droleptan Review and Droleptan Label ), SEVORANE (View Sevorane Review and Sevorane Label ).

5947026-4 | Hypotonia Neonatal
Patient was taking Naropeine (View Usage). Patient had the following side effects: hypotonia neonatal on Oct 30, 2008 from FRANCE Additional patient health information: Male patient , weighting 8.38 lb, . Naropeine dosage: . Patient was hospitalized.

5835476-6 | Bradycardia, Convulsion, Oxygen Saturation Decreased, Rash
Adverse event was reported on Jul 30, 2008 by a Male patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: FRANCE , weighting 68.34 lb, After Naropeine was administered, patient had the following side effects: bradycardia, convulsion, oxygen saturation decreased, rash (What is rash?). During the same period patient was treated with MOPRAL (View Mopral Review and Mopral Label ), SUFENTA (View Sufenta Review and Sufenta Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NALBUPHINE (View Nalbuphine Review and Nalbuphine Label ). Patient was hospitalized.

5828553-7 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jul 21, 2008 Female patient from FRANCE , 45 years of age, weighting 154.3 lb, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.


5806051-4 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jul 01, 2008 Female patient from FRANCE , 45 years of age, weighting 154.3 lb, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5760000-6 | Hypotension
Patient was taking Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: hypotension on Jun 02, 2008 from FRANCE Additional patient health information: Female patient , 75 years of age, . Naropeine dosage: .

5568632-5 |
Adverse event was reported on Dec 07, 2007 by a Male patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia, antibiotic prophylaxis, pain (What is pain?), labour pain, anxiety (What is anxiety?) and. Location: FRANCE , weighting 6.39 lb, . During the same period patient was treated with ERYTHROMYCIN ETHYLSUCCINATE (View Erythromycin Ethylsuccinate Review and Erythromycin Ethylsuccinate Label ), SUFENTA (View Sufenta Review and Sufenta Label ), NUBAIN (View Nubain Review and Nubain Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), ATARAX (View Atarax Review and Atarax Label ).

5386735-5 | Femoral Nerve Injury, Monoplegia, Sensory Loss
on Jul 06, 2007 Female patient from FRANCE , weighting 145.5 lb, was diagnosed with procedural pain and was treated with Naropeine (View Usage). Patient had the following side effects: femoral nerve injury, monoplegia, sensory loss. Naropeine dosage: .

5355921-2 | Anaphylactic Shock, Cardiac Arrest, Convulsion
on Jun 11, 2007 Female patient from FRANCE , 45 years of age, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5346156-8 | Anaphylactic Shock, Cardiac Arrest, Convulsion
Patient was taking Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, cardiac arrest (What is cardiac arrest?), convulsion on Jun 01, 2007 from FRANCE Additional patient health information: Female patient , 45 years of age, was diagnosed with local anaesthesia and. Naropeine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), LASIX (View Lasix Review and Lasix Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), MIMPARA (View Mimpara Review and Mimpara Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), UN ALFA (View Un-alfa Review and Un-alfa Label ), ARANESP (View Aranesp Review and Aranesp Label ). Patient was hospitalized.

5312689-3 | Cardiac Arrest, Hypoproteinaemia, Overdose, Respiratory Arrest, Ventricular Fibrillation
Adverse event was reported on Apr 26, 2007 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia and. Location: FRANCE , weighting 143.3 lb, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, respiratory arrest, ventricular fibrillation. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5312424-9 | Injection Site Infection
on Apr 26, 2007 Male patient from FRANCE , 59 years of age, was diagnosed with postoperative analgesia, infection prophylaxis and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: injection site infection. Naropeine dosage: . During the same period patient was treated with OFLOCET (View Oflocet Review and Oflocet Label ). Patient was hospitalized.

5302181-4 | Paraesthesia, Sciatica
on Apr 17, 2007 Male patient from FRANCE , 55 years of age, was diagnosed with local anaesthesia, liver transplant (What is liver transplant?) and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: paraesthesia, sciatica (What is sciatica?). Naropeine dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ).

5272893-X | Neuromuscular Block Prolonged
Patient was taking Naropeine (View Usage). Patient had the following side effects: neuromuscular block prolonged on Mar 09, 2007 from FRANCE Additional patient health information: Female patient , 60 years of age, was diagnosed with local anaesthesia, sedation and. Naropeine dosage: . During the same period patient was treated with HYPNOVEL (View Hypnovel Review and Hypnovel Label ).

5268238-1 | Epilepsy
Adverse event was reported on Mar 05, 2007 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with epidural anaesthesia and. Location: FRANCE , 26 years of age, After Naropeine was administered, patient had the following side effects: epilepsy (What is epilepsy?).

5249869-1 | Cardiac Arrest, Hypoproteinaemia, Overdose, Respiratory Arrest, Ventricular Fibrillation
on Feb 19, 2007 Female patient from FRANCE , weighting 143.3 lb, was diagnosed with postoperative analgesia and was treated with Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, respiratory arrest, ventricular fibrillation. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ETOMIDATE (View Etomidate Review and Etomidate Label ), NIMBEX (View Nimbex Review and Nimbex Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

5226256-3 | Cardiac Arrest, Hypoproteinaemia, Overdose, Ventricular Fibrillation
on Jan 19, 2007 Female patient from FRANCE , 65 years of age, was diagnosed with postoperative analgesia and was treated with Naropeine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoproteinaemia, overdose, ventricular fibrillation. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5223746-4 | Cardiac Arrest, Hyperproteinaemia, Overdose, Ventricular Fibrillation
Patient was taking Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hyperproteinaemia, overdose, ventricular fibrillation on Jan 19, 2007 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with postoperative analgesia and. Naropeine dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5173218-0 | Cardiac Arrest, Overdose, Ventricular Fibrillation
Adverse event was reported on Dec 08, 2006 by a Female patient taking Naropeine (View Usage) (Dosage: ) was diagnosed with postoperative analgesia and. Location: FRANCE , 65 years of age, Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), overdose, ventricular fibrillation. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ).

5164614-6 | Agitation, Cardiac Arrest, Convulsion, Hallucination, Muscle Rigidity, Respiratory Arrest
on Nov 30, 2006 Male patient from FRANCE , 42 years of age, was diagnosed with local anaesthesia and was treated with Naropeine (View Usage). Patient had the following side effects: agitation, cardiac arrest (What is cardiac arrest?), convulsion, hallucination, muscle rigidity, respiratory arrest. Naropeine dosage: .

5143405-6 | Peripheral Sensory Neuropathy
on Dec 06, 2005 Male patient from FRANCE , 45 years of age, was diagnosed with local anaesthesia, epilepsy (What is epilepsy?) and was treated with Naropeine (View Usage). After Naropeine was administered, patient had the following side effects: peripheral sensory neuropathy. Naropeine dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ).

5136271-6 | Neuromuscular Block Prolonged
Patient was taking Naropeine (View Usage). Patient experienced the following unwanted or unexpected effects: neuromuscular block prolonged on Oct 10, 2006 from FRANCE Additional patient health information: Female patient , 35 years of age, weighting 125.7 lb, was diagnosed with spinal anaesthesia and. Naropeine dosage: . Patient was hospitalized.